I'm always working toward health equity. My goal is to bring the same innovative approaches and great outcomes to all patients.
Where I see patients (1)
Selected research
-
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL.
Blood advances
-
Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel.
Blood advances
-
The impact of environmental contaminants, air pollution, and social deprivation on childhood leukemia survival in California.
Frontiers in oncology
Clinical trials
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Trans...
Clinically significant CMV is defined as the first of (1) initiation of anti-CMV preemptive therapy for documented CMV DNAemia or (2) onset of CMV end-organ disease. Will estimate the cumulative incidence of clinically significant...
Recruiting
More about this studyContact me
Translation, please
We have interpreters for Cantonese, Mandarin, Spanish, Russian, American Sign Language and more.
Request an interpreter
